153 related articles for article (PubMed ID: 35273730)
21. Nonmetastatic osteosarcoma of the extremity. Neoadjuvant chemotherapy with methotrexate, cisplatin, doxorubicin and ifosfamide. An Italian Sarcoma Group study (ISG/OS-Oss).
Ferrari S; Meazza C; Palmerini E; Tamburini A; Fagioli F; Cozza R; Ferraresi V; Bisogno G; Mascarin M; Cefalo G; Manfrini M; Capanna R; Biagini R; Donati D; Picci P
Tumori; 2014; 100(6):612-9. PubMed ID: 25688494
[TBL] [Abstract][Full Text] [Related]
22. The efficacy and safety comparison of first-line chemotherapeutic agents (high-dose methotrexate, doxorubicin, cisplatin, and ifosfamide) for osteosarcoma: a network meta-analysis.
Zhang B; Zhang Y; Li R; Li J; Lu X; Zhang Y
J Orthop Surg Res; 2020 Feb; 15(1):51. PubMed ID: 32054494
[TBL] [Abstract][Full Text] [Related]
23. A phase II study of cisplatin, doxorubicin, and ifosfamide with peripheral blood stem cell support in patients with skeletal osteosarcoma and variant bone tumors with a poor prognosis.
Patel SR; Papadopolous N; Raymond AK; Donato M; Seong CM; Yasko AW; Lewis VO; Lin PP; Champlin R; Benjamin RS
Cancer; 2004 Jul; 101(1):156-63. PubMed ID: 15222001
[TBL] [Abstract][Full Text] [Related]
24. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
Meyers PA; Schwartz CL; Krailo MD; Healey JH; Bernstein ML; Betcher D; Ferguson WS; Gebhardt MC; Goorin AM; Harris M; Kleinerman E; Link MP; Nadel H; Nieder M; Siegal GP; Weiner MA; Wells RJ; Womer RB; Grier HE;
J Clin Oncol; 2008 Feb; 26(4):633-8. PubMed ID: 18235123
[TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide.
Bacci G; Briccoli A; Ferrari S; Saeter G; Donati D; Longhi A; Manfrini M; Bertoni F; Rimondini S; Monti C; Forni C
Oncol Rep; 2000; 7(2):339-46. PubMed ID: 10671683
[TBL] [Abstract][Full Text] [Related]
26. Phase II study of liposomal muramyl tripeptide in osteosarcoma: the cytokine cascade and monocyte activation following administration.
Kleinerman ES; Jia SF; Griffin J; Seibel NL; Benjamin RS; Jaffe N
J Clin Oncol; 1992 Aug; 10(8):1310-6. PubMed ID: 1634921
[TBL] [Abstract][Full Text] [Related]
27. Randomized phase II evaluation of 6 g/m2 of ifosfamide plus doxorubicin and granulocyte colony-stimulating factor (G-CSF) compared with 12 g/m2 of ifosfamide plus doxorubicin and G-CSF in the treatment of poor-prognosis soft tissue sarcoma.
Worden FP; Taylor JM; Biermann JS; Sondak VK; Leu KM; Chugh R; McGinn CJ; Zalupski MM; Baker LH
J Clin Oncol; 2005 Jan; 23(1):105-12. PubMed ID: 15625365
[TBL] [Abstract][Full Text] [Related]
28. Effects of Curcuminoids on Systemic Inflammation and Quality of Life in Patients with Colorectal Cancer Undergoing Chemotherapy: A Randomized Controlled Trial.
Panahi Y; Saberi-Karimian M; Valizadeh O; Behnam B; Saadat A; Jamialahmadi T; Majeed M; Sahebkar A
Adv Exp Med Biol; 2021; 1328():1-9. PubMed ID: 34981467
[TBL] [Abstract][Full Text] [Related]
29. Treatment of large osteosarcoma in children: new approach.
Kobys VL; Konovalenko VF; Repinа NV; Golovko TS; Gulak LO; Tarasova TO; Zaharycheva EV; Matyushok OF
Exp Oncol; 2013 Jun; 35(2):105-8. PubMed ID: 23828385
[TBL] [Abstract][Full Text] [Related]
30. Effect of Sanhuangyilong decoction plus methotrexate on tumor necrosis factor alpha and interferon gamma in serum and synovial fluid in rheumatoid arthritis patients with symptom pattern of damp heat obstruction.
Liu D; Yan J; Yun M; Yang M; Luo Y; Zhang J; Guo M; Yang M; Yuan W; Zou W; Li H; Hu Y
J Tradit Chin Med; 2016 Oct; 36(5):625-33. PubMed ID: 29933531
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of ifosfamide-based chemotherapy for osteosarcoma: a meta-analysis.
Fan XL; Cai GP; Zhu LL; Ding GM
Drug Des Devel Ther; 2015; 9():5925-32. PubMed ID: 26604690
[TBL] [Abstract][Full Text] [Related]
32. IAP Chemotherapy Regimen Is a Viable and Cost-effective Option in Children and Adolescents With Osteosarcoma: A Comparative Analysis With MAP Regimen on Toxicity and Survival.
Verma P; Jain S; Kapoor G; Tripathi R; Sharma P; Doval DC
J Pediatr Hematol Oncol; 2021 May; 43(4):e466-e471. PubMed ID: 32925402
[TBL] [Abstract][Full Text] [Related]
33. Induction of HLA class II antigens in osteosarcoma cells by interferons and tumor necrosis factor alpha.
Scotlandi K; Baldini N; Campanacci M; Lollini PL; Picci P; Serra M
Anticancer Res; 1992; 12(3):767-72. PubMed ID: 1622136
[TBL] [Abstract][Full Text] [Related]
34. [Effects of agmatine on excessive inflammatory reaction and proliferation of splenic cells in mice with trauma].
Liu Z; Hou F; Jin H; Xiao Y; Fan X; Yang X; Yan J; Liang H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Feb; 27(2):110-4. PubMed ID: 25665609
[TBL] [Abstract][Full Text] [Related]
35. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.
Judson I; Verweij J; Gelderblom H; Hartmann JT; Schöffski P; Blay JY; Kerst JM; Sufliarsky J; Whelan J; Hohenberger P; Krarup-Hansen A; Alcindor T; Marreaud S; Litière S; Hermans C; Fisher C; Hogendoorn PC; dei Tos AP; van der Graaf WT;
Lancet Oncol; 2014 Apr; 15(4):415-23. PubMed ID: 24618336
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic effects of adriamycin combined with high-intensity focused ultrasound on osteosarcoma.
Wang C
J BUON; 2019; 24(2):826-831. PubMed ID: 31128042
[TBL] [Abstract][Full Text] [Related]
37. [Application of apparent diffusion coefficient combined with serum tumor markers detection in evaluating neoadjuvant chemotherapy for osteosarcoma].
Wang Z; Liu L; Song YX; Zhang H; She W; Qian YW
Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(13):1012-1016. PubMed ID: 32294859
[No Abstract] [Full Text] [Related]
38. Vincristine, Ifosfamide, and Doxorubicin for Initial Treatment of Ewing Sarcoma in Adults.
Wagner MJ; Gopalakrishnan V; Ravi V; Livingston JA; Conley AP; Araujo D; Somaiah N; Zarzour MA; Ratan R; Wang WL; Patel SR; Lazar A; Ludwig JA; Benjamin RS
Oncologist; 2017 Oct; 22(10):1271-1277. PubMed ID: 28710342
[TBL] [Abstract][Full Text] [Related]
39. [Role of ash2 (absent, small, or homeotic)-like and Jumonji domain-containing protein 3 on histone methylation of interferon-gamma gene and their associations with vascular damage of Kawasaki disease].
Mei JH; Tang G; Wang Q; Wen PQ; Xu MG; Cui D; Ma DL; Liu C; Wang GB
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Sep; 45(9):791-798. PubMed ID: 29036979
[No Abstract] [Full Text] [Related]
40. Gene expression profiles classify human osteosarcoma xenografts according to sensitivity to doxorubicin, cisplatin, and ifosfamide.
Bruheim S; Xi Y; Ju J; Fodstad O
Clin Cancer Res; 2009 Dec; 15(23):7161-9. PubMed ID: 19920113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
